These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13872435)

  • 1. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G
    Can Psychiatr Assoc J; 1962; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES
    Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract]   [Full Text] [Related]  

  • 3. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology.
    PRUETER GW
    Can Psychiatr Assoc J; 1962; 7(Suppl)():77-83. PubMed ID: 14489022
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
    LESSE S
    N Y State J Med; 1961 Jun; 61():1898-903. PubMed ID: 13761180
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE; TEDESCHI DH; FELLOWS EJ
    Can Psychiatr Assoc J; 1962; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract]   [Full Text] [Related]  

  • 7. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM
    Can Psychiatr Assoc J; 1962; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract]   [Full Text] [Related]  

  • 8. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
    SCHIELE BC
    Am J Psychiatry; 1960 Sep; 117():245-6. PubMed ID: 13747600
    [No Abstract]   [Full Text] [Related]  

  • 9. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
    KRUSE W
    Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined tranlcypromine and trifluoperazine therapy in general medicine.
    LEWIS RA
    Can Psychiatr Assoc J; 1962; 7(Suppl)():74-6. PubMed ID: 14464901
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of stelazine and parnate in chronic, withdrawn patients.
    VOGT AH
    Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857
    [No Abstract]   [Full Text] [Related]  

  • 12. Parstelin in anxiety states and depression.
    HEMPHILL RE; FOSTER AR
    J Coll Gen Pract; 1962 May; 5(2):238-45. PubMed ID: 13906375
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical study of a potent antidepressant: tranylcypromine with trifluoperazine in the aged chronically ill.
    STRAKER M; GRAUER H
    Can Psychiatr Assoc J; 1962; 7(Supl)():96-103. PubMed ID: 13917604
    [No Abstract]   [Full Text] [Related]  

  • 14. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract]   [Full Text] [Related]  

  • 15. The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
    SULZER ES; SCHIELE BC
    Am J Psychiatry; 1962 Jul; 119():69-70. PubMed ID: 13918361
    [No Abstract]   [Full Text] [Related]  

  • 16. DEPRESSIONS... THEIR MANAGEMENT AND TREATMENT.
    WALLING RG
    J Ark Med Soc; 1964 Mar; 60():361-3. PubMed ID: 14127558
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical trial of an antidepressant, tranylcy-promine ("Parnate").
    KINGSTON WR
    Med J Aust; 1962 Jun; 49(1)():1011-2. PubMed ID: 14456153
    [No Abstract]   [Full Text] [Related]  

  • 18. [BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY OF MONOAMINE OXIDASE INHIBITORS: THE ASSOCIATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE IN THE THERAPY OF DEPRESSIVE SYNDROMES].
    GRATTAROLA FR; ROSSO G; ROVERA GG
    Clin Ter; 1963 Sep; 26():406-30. PubMed ID: 14091908
    [No Abstract]   [Full Text] [Related]  

  • 19. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome.
    MAZZA PA
    Dis Nerv Syst; 1962 Apr; 23():224-5. PubMed ID: 14471846
    [No Abstract]   [Full Text] [Related]  

  • 20. Tranylcypromine-trifluoperazine in the management of emotional distress.
    BAUM ES
    Int Rec Med; 1961 May; 174():303-6. PubMed ID: 13687959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.